Literature DB >> 11701773

Differential effects of unaggregated and aggregated amyloid beta protein (1-40) on K(+) channel currents in primary cultures of rat cerebellar granule and cortical neurones.

M Ramsden1, L D Plant, N J Webster, P F Vaughan, Z Henderson, H A Pearson.   

Abstract

The effects of amyloid beta protein on voltage-gated K(+) channel currents were studied using the whole-cell patch-clamp technique. The 1-40 amino acid form of amyloid beta protein was applied to primary cultures of rat cerebellar granule and cortical neurones for 24 h. Both the unaggregated and aggregated forms of the peptide, which have differing biological activities, were used. In cerebellar granule neurones, 24-h pre-incubation with 1 microM unaggregated amyloid beta protein resulted in a 60% increase in the 'A'-type component of K(+) current. Increased delayed rectifier activity was Cd(2+)-sensitive and was presumed to be secondary to an increase in voltage-gated Ca(2+) channel current activity. Unaggregated amyloid beta protein had no effect on any component of the K(+) channel current in cortical neurones. One micromolar of aggregated amyloid beta protein had no effect on K(+) channel current in either cell type but reduced cell survival within 24 h as measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) assays. The unaggregated form of amyloid beta protein had no neurotoxic effects when applied to either neurone type for up to 72 h. These data indicate that the unaggregated, non-pathological form of amyloid beta protein causes changes in the ion channel function of neurones, possibly reflecting a physiological role for the peptide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701773     DOI: 10.1046/j.1471-4159.2001.00618.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  The amyloid-beta precursor protein: integrating structure with biological function.

Authors:  Constanze Reinhard; Sébastien S Hébert; Bart De Strooper
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

2.  The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study.

Authors:  Nikolaos G Sgourakis; Yilin Yan; Scott A McCallum; Chunyu Wang; Angel E Garcia
Journal:  J Mol Biol       Date:  2007-03-07       Impact factor: 5.469

Review 3.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

4.  Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure.

Authors:  Jorge Parodi; Fernando J Sepúlveda; Jorge Roa; Carlos Opazo; Nibaldo C Inestrosa; Luis G Aguayo
Journal:  J Biol Chem       Date:  2009-11-13       Impact factor: 5.157

5.  Amyloid-beta1-42 reduces neuronal excitability in mouse dentate gyrus.

Authors:  Sung Hwan Yun; Georgi Gamkrelidze; W Blaine Stine; Patrick M Sullivan; Joseph F Pasternak; Mary Jo Ladu; Barbara L Trommer
Journal:  Neurosci Lett       Date:  2006-06-12       Impact factor: 3.046

Review 6.  Amyloid-β as a modulator of synaptic plasticity.

Authors:  Mordhwaj S Parihar; Gregory J Brewer
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  What is the dominant Abeta species in human brain tissue? A review.

Authors:  Gillian C Gregory; Glenda M Halliday
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 8.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

Review 9.  Prion protein and Alzheimer disease.

Authors:  Katherine A B Kellett; Nigel M Hooper
Journal:  Prion       Date:  2009-10-02       Impact factor: 3.931

10.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.